Search Results

You are looking at 1 - 10 of 493 items for :

  • "colorectal cancer" x
Clear All
Full access

Randall W. Burt, Jamie A. Cannon, Donald S. David, Dayna S. Early, James M. Ford, Francis M. Giardiello, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Kory Jasperson, Jason B. Klapman, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe Shike, Gideon Steinbach, Jonathan P. Terdiman, David Weinberg, Mary Dwyer and Deborah Freedman-Cass

Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer in the United States. In 2012, an estimated 102,480 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States. During the same year, an estimated 50

Full access

Joleen M. Hubbard and Axel Grothey

Incidence of Colorectal Cancer in Adolescents and Young Adults The incidence of colorectal cancer (CRC) in young adults is relatively low. CRC is typically a disease of older adults, with the average age of colon cancer diagnosis approaching

Full access

Robin K. Kelley, Grace Wang and Alan P. Venook

(MSI) testing in management of patients with stage II colon cancer Describe the role of KRAS mutational analysis in management of patients with metastatic colorectal cancers Describe the role of BRAF mutational analysis in management of patients with

Full access

Matthew F. Kalady

cytoplasm. 2 Expert opinion suggests that SSA/Ps with cytologic dysplasia be considered to have at least the same colorectal cancer (CRC) risk as adenomas with high-grade dysplasia. 2 Another form of dysplasia can be seen in SSA/Ps, termed serrated

Full access

Randall W. Burt, James S. Barthel, Kelli Bullard Dunn, Donald S. David, Ernesto Drelichman, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley R. Hamilton, Mohammad K. Ismail, Kory Jasperson, Audrey J. Lazenby, Patrick M. Lynch, Edward W. Martin Jr., Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe Shike, Gideon Steinbach, Jonathan P. Terdiman and David Weinberg

Colorectal Cancer Screening Clinical Practice Guidelines in Oncology NCCN Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform NCCN

Full access

Alan P. Venook

At the NCCN 21st Annual Conference, Alan P. Venook, MD, from UCSF Helen Diller Family Comprehensive Cancer Center, looked back for “lessons learned” in the treatment of metastatic colorectal cancer (mCRC) and peered into the future to gauge how

Full access

Kristen Keon Ciombor and Tanios Bekaii-Saab

personalized therapy for patients with mCRC Colorectal cancer (CRC) is both the third most prevalent and third most fatal tumor type in the United States, with an estimated 143,460 new cases and 51,690 deaths in 2012 alone. 1 Although surgical resection

Full access

Joseph Rosales and Lucille A. Leong

discussed in the article or their competitors. References 1 Poon MA O'Connell MJ Wieand HS . Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer . J Clin

Full access

Dawn Provenzale, Kory Jasperson, Dennis J. Ahnen, Harry Aslanian, Travis Bray, Jamie A. Cannon, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, Samir Gupta, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, M. Sambasiva Rao, Scott E. Regenbogen, Moshe Shike, Gideon Steinbach, David Weinberg, Mary A. Dwyer, Deborah A. Freedman-Cass and Susan Darlow

, participants will be able to: Integrate into professional practice the updates to the NCCN Guidelines for Colorectal Cancer Screening Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Colorectal Cancer

Full access

Fikri İçli, Hakan Akbulut, Shouki Bazarbashi, Mehmet Ayhan Kuzu, Mohandas K. Mallath, Kakil Ibrahim Rasul, Scott Strong, Aamir Ali Syed, Faruk Zorlu and Paul F. Engstrom

colorectal cancer should ideally be based on evidence-based medicine, standardized practices do not exist in other parts of the world. The social, cultural, and economic differences among the countries may be responsible for this lack of standard management